Kevin F Boehnke
Biographic Data
| ID | 1936336 |
|---|---|
| NAME | Kevin F Boehnke |
| GIVEN NAMES | Kevin F |
| FAMILY NAME | Boehnke |
| SIGNATURE | BOEHNKE K F |
| AFFILIATIONS | University of Michigan |
| ORCID | 0000-0003-3696-3979 |
| VERIFIED | Yes |
| TOTAL WORKS | 19 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 19 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Minor Cannabinoid Use Among Medical Cannabis Patients
The legalization of cannabis in the United States (US) has increased the availability of a variety of novel cannabinoids such as cannabigerol (CBG) and cannabinol (CBN), delta-8 tetrahydrocannabinol (delta-8 THC) and THC-O acetate ester (THC-O), yet little is understood about the use of these emerging cannabinoids by medical cannabis patients. A large sample ( N = 1721) of US medical cannabis patients was surveyed to characterize their patterns o…
Racial Differences in Naturalistic Psychedelic Use — Motivations for Use, Communication with Health Care Providers, and Outcomes
People of Color have been under-included in psychedelic-assisted therapy (PAT) research. Researchers have argued that systemic issues resulting in harms to communities of color like the War on Drugs and recurrent exposure to discrimination in healthcare settings may reduce their willingness to engage in PAT research. However, there are no empirical data regarding People of Color's trust or willingness in using psychedelics with support of trained…
Tripping into Treatment
Psychedelic drugs are currently being explored for their therapeutic potential for a variety of health conditions. The recent increased public interest in psychedelics necessitates empirical investigation into motivations for use among users as well as how motivations may change over time. We asked a large sample of participants reporting naturalistic psychedelic use ( N = 1221) about their motivations for using psychedelics initially (i.e. their…
Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics
Systematic research on the impact of psychedelic use on sexuality and intimacy remains limited. This study investigated reported effects of psychedelic use on various aspects of sexuality, gender, and relationships through an online survey of individuals who had used psychedelics ( N = 581). Most participants (70.2%) reported perceived impacts of psychedelic experiences on their sexuality and/or sexual experiences, with 65.4% noting short-term ef…
Psychedelic substitution
Although limited by cross-sectional study design, this large observational study will help inform future studies aiming to investigate the relationship between substance use patterns and psychedelic use
Going Underground
Psychedelic-assisted therapy (PAT) has shown preliminary efficacy for psychiatric and physical health conditions. Although some people report naturalistic psychedelic use with so-called "underground" practitioners, little is known about PAT that occurs outside of controlled clinical settings or perspectives of these practitioners. We conducted an anonymous online survey of individuals who reported providing psychedelic support services (e.g. trip…
Highs and Lows
Presently, 24 states have legalized adult use (recreational) cannabis, each following medical-only access. Although states that pass adult use laws report substantial declines in the number of registered medical patients, these laws expand the market, potentially enhancing patient benefits. However, research on federal adult use cannabis legislation in Canada suggests that adult use laws negatively impact medical patients. The purpose of this mix…
Data Quality in State Registry Reports of Medical Cannabis Patients in the United States
Objectives. To investigate characteristics of data reported in US medical cannabis registries across states. Methods. Data included 2021 medical cannabis registry reports from 34 states, Puerto Rico, and the District of Columbia (hereafter, states) with active medical cannabis programs. The data from the reports were manually coded into domains and subcategories, including information related to patients (e.g., number, demographics), authorizing …
Attitudes of psychedelic users regarding cost of treatment and non-hallucinogenic alternatives
Background and aimsPsychedelic-assisted psychotherapy (PAP) is currently being studied as a possible treatment option for multiple disorders. Despite promising safety and efficacy findings, the high costs of the current PAP model makes it questionable if the treatment will be scalable. Non-hallucinogenic psychedelic analogs have been developed as a potential cost-effective alternative, but it is unclear what psychedelic users perceive as a reason…
Slouching towards engagement
Introduction There is substantial public interest in psychedelics as potential treatments for psychiatric conditions. However, most psychedelics are criminalized under federal law in the USA, so it is unclear whether use occurs with clinical support. Our objective was to assess whether naturalistic psychedelic use occurs with clinical support, interactions between those using psychedelics and healthcare providers (psychiatrist, therapist, or prim…
Changed Substance Use After Psychedelic Experiences Among Individuals in Canada
How Do I Learn More About this?”
There is a surge of interest in psychedelics, including new stakeholders and greater media attention. There is a need to examine the information-seeking behavior of people using psychedelics naturalistically, given the importance of preparation and harm-reduction. We examined sources of information for people using psychedelics naturalistically, and the degree to which they are trusted in a large, anonymous, online survey ( N = 1221). The most co…
Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics
Legal, scientific, and social landscapes for psychedelics are changing rapidly. Differences of opinion exist among key stakeholders regarding regulatory control, models of provisioning psychedelic therapy, and medicalization, decriminalization, and/or legalization policies. We assessed the policy preferences of people using psychedelics naturalistically ( N = 1221) to understand how they aligned and differed with institutional entities and existi…
The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada
Naturalistic psychedelic use among Canadians is common. However, interactions about psychedelic use between patients and clinicians in Canada remain unclear. Via an anonymous survey, we assessed health outcomes and integration of psychedelic use with health care providers (HCP) among Canadian adults reporting past use of a psychedelic. The survey included 2,384 participants, and most (81.2%) never discussed psychedelic use with their HCP. While 3…
Applying Lessons From Cannabis to the Psychedelic Highway
In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers. Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of psychedelics for psychiatric conditions 2,3 and the e…
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia
Fibromyalgia (FM) is a difficult to treat chronic pain condition for which there is strong interest in alternative treatments. There is growing interest in the potential of psychedelic substances (e.g., psilocybin) in conjunction with psychotherapy to treat chronic pain. Via a cross-sectional, anonymous, online survey, we aimed to characterize knowledge, perceptions, and past use of serotonergic ("classic") and non-serotonergic psychedelics among…
Naturalistic Psychedelic Use
Interest in and availability of psychedelics for therapeutic purposes has increased in recent decades. In a large, anonymous, online survey, we investigated patterns of communication with healthcare providers and awareness and utilization of substance testing kits or services among people using psychedelics naturalistically. The sample population included attendees of a psychedelic activism event and users of psychedelic social media forums. Amon…
An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically
Identifying gaps and strengths in psychedelic-related knowledge is key to developing effective, evidence-based education to inform appropriate use of and harm reduction practices for psychedelics in the naturalistic use landscape. The current study piloted an assessment instrument with questions on legal status, therapeutic potential, and side effects of psychedelics among people reporting current psychedelic use. We recruited participants ( N = …
Medication and substance use increases among people using cannabis medically during the Covid-19 pandemic
No prominent works on this page.
Medication and substance use increases among people using cannabis medically during the Covid-19 pandemic
Applying Lessons From Cannabis to the Psychedelic Highway
In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers. Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of psychedelics for psychiatric conditions 2,3 and the e…
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia
Fibromyalgia (FM) is a difficult to treat chronic pain condition for which there is strong interest in alternative treatments. There is growing interest in the potential of psychedelic substances (e.g., psilocybin) in conjunction with psychotherapy to treat chronic pain. Via a cross-sectional, anonymous, online survey, we aimed to characterize knowledge, perceptions, and past use of serotonergic ("classic") and non-serotonergic psychedelics among…
Naturalistic Psychedelic Use
Interest in and availability of psychedelics for therapeutic purposes has increased in recent decades. In a large, anonymous, online survey, we investigated patterns of communication with healthcare providers and awareness and utilization of substance testing kits or services among people using psychedelics naturalistically. The sample population included attendees of a psychedelic activism event and users of psychedelic social media forums. Amon…
An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically
Identifying gaps and strengths in psychedelic-related knowledge is key to developing effective, evidence-based education to inform appropriate use of and harm reduction practices for psychedelics in the naturalistic use landscape. The current study piloted an assessment instrument with questions on legal status, therapeutic potential, and side effects of psychedelics among people reporting current psychedelic use. We recruited participants ( N = …
Slouching towards engagement
Introduction There is substantial public interest in psychedelics as potential treatments for psychiatric conditions. However, most psychedelics are criminalized under federal law in the USA, so it is unclear whether use occurs with clinical support. Our objective was to assess whether naturalistic psychedelic use occurs with clinical support, interactions between those using psychedelics and healthcare providers (psychiatrist, therapist, or prim…
Changed Substance Use After Psychedelic Experiences Among Individuals in Canada
How Do I Learn More About this?”
There is a surge of interest in psychedelics, including new stakeholders and greater media attention. There is a need to examine the information-seeking behavior of people using psychedelics naturalistically, given the importance of preparation and harm-reduction. We examined sources of information for people using psychedelics naturalistically, and the degree to which they are trusted in a large, anonymous, online survey ( N = 1221). The most co…
Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics
Legal, scientific, and social landscapes for psychedelics are changing rapidly. Differences of opinion exist among key stakeholders regarding regulatory control, models of provisioning psychedelic therapy, and medicalization, decriminalization, and/or legalization policies. We assessed the policy preferences of people using psychedelics naturalistically ( N = 1221) to understand how they aligned and differed with institutional entities and existi…
The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada
Naturalistic psychedelic use among Canadians is common. However, interactions about psychedelic use between patients and clinicians in Canada remain unclear. Via an anonymous survey, we assessed health outcomes and integration of psychedelic use with health care providers (HCP) among Canadian adults reporting past use of a psychedelic. The survey included 2,384 participants, and most (81.2%) never discussed psychedelic use with their HCP. While 3…
Psychedelic substitution
Although limited by cross-sectional study design, this large observational study will help inform future studies aiming to investigate the relationship between substance use patterns and psychedelic use
Going Underground
Psychedelic-assisted therapy (PAT) has shown preliminary efficacy for psychiatric and physical health conditions. Although some people report naturalistic psychedelic use with so-called "underground" practitioners, little is known about PAT that occurs outside of controlled clinical settings or perspectives of these practitioners. We conducted an anonymous online survey of individuals who reported providing psychedelic support services (e.g. trip…
Highs and Lows
Presently, 24 states have legalized adult use (recreational) cannabis, each following medical-only access. Although states that pass adult use laws report substantial declines in the number of registered medical patients, these laws expand the market, potentially enhancing patient benefits. However, research on federal adult use cannabis legislation in Canada suggests that adult use laws negatively impact medical patients. The purpose of this mix…
Data Quality in State Registry Reports of Medical Cannabis Patients in the United States
Objectives. To investigate characteristics of data reported in US medical cannabis registries across states. Methods. Data included 2021 medical cannabis registry reports from 34 states, Puerto Rico, and the District of Columbia (hereafter, states) with active medical cannabis programs. The data from the reports were manually coded into domains and subcategories, including information related to patients (e.g., number, demographics), authorizing …
Attitudes of psychedelic users regarding cost of treatment and non-hallucinogenic alternatives
Background and aimsPsychedelic-assisted psychotherapy (PAP) is currently being studied as a possible treatment option for multiple disorders. Despite promising safety and efficacy findings, the high costs of the current PAP model makes it questionable if the treatment will be scalable. Non-hallucinogenic psychedelic analogs have been developed as a potential cost-effective alternative, but it is unclear what psychedelic users perceive as a reason…
Minor Cannabinoid Use Among Medical Cannabis Patients
The legalization of cannabis in the United States (US) has increased the availability of a variety of novel cannabinoids such as cannabigerol (CBG) and cannabinol (CBN), delta-8 tetrahydrocannabinol (delta-8 THC) and THC-O acetate ester (THC-O), yet little is understood about the use of these emerging cannabinoids by medical cannabis patients. A large sample ( N = 1721) of US medical cannabis patients was surveyed to characterize their patterns o…
Racial Differences in Naturalistic Psychedelic Use — Motivations for Use, Communication with Health Care Providers, and Outcomes
People of Color have been under-included in psychedelic-assisted therapy (PAT) research. Researchers have argued that systemic issues resulting in harms to communities of color like the War on Drugs and recurrent exposure to discrimination in healthcare settings may reduce their willingness to engage in PAT research. However, there are no empirical data regarding People of Color's trust or willingness in using psychedelics with support of trained…
Tripping into Treatment
Psychedelic drugs are currently being explored for their therapeutic potential for a variety of health conditions. The recent increased public interest in psychedelics necessitates empirical investigation into motivations for use among users as well as how motivations may change over time. We asked a large sample of participants reporting naturalistic psychedelic use ( N = 1221) about their motivations for using psychedelics initially (i.e. their…
Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics
Systematic research on the impact of psychedelic use on sexuality and intimacy remains limited. This study investigated reported effects of psychedelic use on various aspects of sexuality, gender, and relationships through an online survey of individuals who had used psychedelics ( N = 581). Most participants (70.2%) reported perceived impacts of psychedelic experiences on their sexuality and/or sexual experiences, with 65.4% noting short-term ef…
Psychedelics and Drug Studies (16 works) · Psychiatry (15 works) · Psychology (15 works) · Chemical synthesis and alkaloids (12 works) · Medicine (10 works) · Clinical Psychology (9 works) · Clinical Psychology (9 works) · Social Psychology (8 works) · Cannabis (7 works) · Social Psychology (7 works)